Advertisement

Alzheimer Disease

From Molecular Biology to Theraphy

  • Robert E. Becker
  • Ezio Giacobini
  • Joyce M. Barton
  • Mona Brown

Part of the Advances in Alzheimer Disease Therapy book series (AADT)

Table of contents

  1. Front Matter
    Pages i-xiv
  2. Pathological Basis of Therapy in Alzheimer Disease

    1. Front Matter
      Pages 1-1
    2. Criteria for the Diagnosis of Alzheimer’s Disease

      1. Helena Chui, Qian Zhang, Jeff Victoroff, Barbara Zaias
        Pages 13-17
    3. Neuropathology Of Alzheimer’s Disease

      1. Constantin Bouras, Pandelis Giannakopoulos, Philippe G. Vallet
        Pages 25-29
      2. Khalid Iqbal, Alejandra C. del Alonso, Cheng-Xin Gong, Niloufar Haque, Sabiha Khatoon, Takashi Kudo et al.
        Pages 31-36
      3. Jean-Pierre Michel, Pius Muller, Gabriel Gold, Willliam Mac Gee, Reihnild Mulligan, Constantin Bouras
        Pages 37-46
    4. Processing of Amyloid, Cytoskeletal Damage and Apolipoproteins

      1. Judes Poirier, Isabelle Aubert, Rémi Quirion, Serge Gauthier, Martin Farlow, Josephine Nalbantoglu et al.
        Pages 55-60
      2. Hugo Geerts, Rony Nuydens, Mirjam de Jong, Gerd van de Kieboom
        Pages 61-65
      3. Nathalie Chevallier, Philippe Marambaud, Jean-Pierre Vincent, Frédéric Checler, Jean Vizzavona, Pierre Fulcrand et al.
        Pages 67-73
      4. Henryk M. Wisniewski, Janusz Frackowiak, Bozena Mazur-Kolecka, Jerzy Wegiel, Abha Chauhan, Ved P. S. Chauhan
        Pages 75-80
      5. Giancarlo Pepeu, Lisa Giovannelli, Fiorella Casamenti, Carla Scali
        Pages 81-85
      6. Gerda S. Huber, Jean-Luc Moreau, James R. Martin, Yannick Bailly, Jean Mariani, Bernard Brugg
        Pages 87-90
      7. Claudio Soto, Frances Prelli, Blas Frangione, Mark S. Kindy, Frederick de Beer
        Pages 91-97
    5. Cell Death: Excitotoxins, Apoptosis and Hypometabolism

      1. John Olney, David Wozniak, Masahiko Ishimaru, Nuri Färber
        Pages 107-112
    6. Neurotrophic, Growth Factors and Neuroprotectors

    7. Animal Models

      1. Hui Zheng, Gurparkash Singh, Minghao Jiang, Myrna Trumbauer, Howard Chen, Lex van der Ploeg et al.
        Pages 133-136
      2. Markus Björklund, Minna Riekkinen, Paavo Riekkinen Jr., Jukka Sallinen, Mika Scheinin, Jouni Sirviö et al.
        Pages 137-143
      3. Paula M. Moran, Paul C. Moser, Linda S. Higgins, Barbara Cordell
        Pages 145-150
  3. The Cholinergic System in Brain

    1. Front Matter
      Pages 151-151
    2. Treatment of Alzheimer Disease

      1. Daniela Kaufer-Nachum, Alon Friedman, Meira Sternfeld, Shlomo Seidman, Rachel Beeri, Christian Andres et al.
        Pages 153-157
      2. Mario Brufani, Luigi Filocamo
        Pages 171-177
    3. Cholinesterase Inhibitors in Alzheimer Disease Treatment

      1. Stephen Gracon, Fraser Smith, Toni Hoover, David Knopman, Lon Schneider, Kenneth Davis et al.
        Pages 205-209
      2. Albert Enz, Philipp Floersheim
        Pages 211-215
      3. Bernard H. Schmidt, Volker C. Hinz, Arjan Blokland, Franz-Josef van der Staay, Richard J. Fanelli
        Pages 217-221
      4. Nigel H. Greig, Donald K. Ingram, William C. Wallace, Tadanobu Utsuki, Qian-Sheng Yu, Harold W. Holloway et al.
        Pages 231-237
      5. Ravi Anand, Richard D. Hartman, Peggy E. Hayes, Marguirguis Gharabawi
        Pages 239-243
      6. Hugo M. Vargas, Craig P. Smith, Mary Li, Gina M. Bores, Andrew Giovanni, Lily Zhou et al.
        Pages 251-255
      7. Robert E. Becker, Pamela Moriearty, Latha Unni, Sandra Vicari
        Pages 257-266
  4. Nicotinic and Muscarinic Cholinergic Agonists

    1. Front Matter
      Pages 267-267
    2. Nicotinic Agonists

      1. Hannsjörg Schröder, Andrea Wevers, Elke Happich, Ulrich Schütz, Natasha Moser, Robert A.I. de Vos et al.
        Pages 269-273
      2. Jennifer A. Court, Stephen Lloyd, Robert H. Perry, Martin Griffiths, Christopher Morris, Mary Johnson et al.
        Pages 275-279
      3. Patrick M. Lippiello, Merouane Bencherif, William S. Caldwell, Sherry R. Arrington, Kathy W. Fowler, M. Elisa Lovette et al.
        Pages 281-286
      4. Stephen P. Arnerić, Anthony W. Bannon, Jorge D. Brioni, Clark A. Briggs, Michael W. Decker, Mark W. Holladay et al.
        Pages 287-291
    3. Musacarinic Agonists and Antagonists

      1. Mark R. Emmerling, Michael J. Callahan, William J. Lipinski, M. Duff Davis, Leonard Cooke, Howard Bockbrader et al.
        Pages 293-297
      2. Rajinder Kumar, Eve Cedar, Michael S. G. Clark, Julia M. Loudon, James P. C. McCafferty
        Pages 299-303
      3. Hervé Allain, David Guez, Eric Neuman, Muriel Malbezin, Jean Lepagnol, Florence Mahieux
        Pages 305-310
      4. Roy D. Schwarz, Michael J. Callahan, Robert E. Davis, Mark R. Emmerling, Juan C. Jaen, William Lipinski et al.
        Pages 311-315

About this book

Keywords

Alzheimer Assessment Depression anatomy biology dementia dynamics forebrain metabolism molecular biology neurons

Editors and affiliations

  • Robert E. Becker
    • 1
  • Ezio Giacobini
    • 2
  • Joyce M. Barton
  • Mona Brown
  1. 1.Department of PsychiatrySouthern Illinois University School of MedicineSpringfieldUSA
  2. 2.Institutions Universitaires de Geriatrie de GeneveThonex, GenevaSwitzerland

Bibliographic information